Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 171126204 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Ikarian Capital, LLC
13G/A
Amendment 3
|
7.7% |
5/15/2026
Event 3/31/2026
|
|
| Ikarian Capital, LLC | 7.7% | ||
| Neil Shahrestani | 7.7% | ||
|
3i, LP
13G/A
Amendment 2
|
9.9% |
5/7/2026
Event 3/31/2026
|
|
| 3i, LP | 9.9% | ||
| 3i Management LLC | 9.9% | ||
| Maier Joshua Tarlow | 9.9% | ||
|
Ikarian Capital, LLC
13G/A
Amendment 2
|
8.4% |
2/17/2026
Event 12/31/2025
|
|
| Ikarian Capital, LLC | 8.4% | ||
| Neil Shahrestani | 8.4% | ||
|
3i, LP
13G/A
Amendment 1
|
9.9% |
2/5/2026
Event 12/31/2025
|
|
| 3i, LP | 9.9% | ||
| 3i Management LLC | 9.9% | ||
| Maier Joshua Tarlow | 9.9% | ||
|
Murchinson Ltd.
13G
|
9.1% |
11/14/2025
Event 9/30/2025
|
|
| Murchinson Ltd. | 9.1% | ||
| Marc Bistricer | 9.1% | ||
|
Ikarian Capital, LLC
13G/A
Amendment 1
|
6.1% |
11/14/2025
Event 9/30/2025
|
|
| Ikarian Capital, LLC | 6.1% | ||
| Neil Shahrestani | 6.1% | ||
| Ligand Pharmaceuticals Inc 13D/A Amendment 1 | 49.9% |
11/10/2025
Event 11/6/2025
|
|
|
AME Equities LLC
13G/A
Amendment 1
|
0% |
8/13/2025
Event 6/30/2025
|
|
| AME Equities LLC | 0% | ||
| Ruth Friedman | 0% | ||
|
3i, LP
13G
|
9.9% |
7/8/2025
Event 7/1/2025
|
|
| 3i, LP | 9.9% | ||
| 3i Management LLC | 9.9% | ||
| Maier Joshua Tarlow | 9.9% | ||
|
Friedberg Ezra M
13D/A
Amendment 1
|
8.3% |
7/3/2025
Event 7/1/2025
|
|
| Ezra Friedberg | 8.3% | ||
| Balmoral Financial Group LLC | 3.1% | ||
| Key Recovery Group LLC | 1.3% | ||
| Ligand Pharmaceuticals Inc 13D | 49.9% |
7/3/2025
Event 7/1/2025
|